Nasdaq:US$13.64 (-0.17) | HKEX:HK$20.55 (-0.50) | AIM:£2.19 (-0.08)
新聞中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科學出版物 | 2014-06-03

ASCO 2014: A phase 1b study of VEGFR inhibitor fruquintinib in patients with pretreated advanced colorectal cancer